May 2026
1. CANTU-MARTINEZ O, Fudim M, Kong DF, Tedford RJ, et al
   Accuracy of site versus core laboratory interpretations of right heart catheterization hemodynamics.
   Am Heart J. 2026;295:107351.
   

   >> Share

   
   February 2026
2. ATLURI N, Herty L, Runge C, Wells J, et al
   Remote dietitian counseling with short-term meal delivery improves DASH diet adherence and lowers blood pressure in veterans with hypertension and obesity.
   Am Heart J. 2026 Feb 24:107386. doi: 10.1016/j.ahj.2026.107386.
   

   >> Share

   
   
3. CHEN W, Musa AZ, Odubela O, Onakomaiya D, et al
   Integration of a task strengthening strategy for hypertension management into HIV care in Nigeria: Baseline characteristics of participants in a cluster randomized controlled trial.
   Am Heart J. 2026 Feb 17:107383. doi: 10.1016/j.ahj.2026.107383.
   

   >> Share

   
   
4. MARTINS E, Tavares CAM, Favaro L, Monfardini F, et al
   Rationale and Design of a Pragmatic Randomized Clinical Trial Assessing a Smartphone-Based Digital Health Intervention in Hypertension: The ELFIE-HYPERTENSION trial.
   Am Heart J. 2026 Feb 10:107380. doi: 10.1016/j.ahj.2026.107380.
   

   >> Share

   
   January 2026
5. RASMUSSEN PV, Strange JE, Nielsen SK, Hansen RB, et al
   Beta-blocker side-effects in clinical practice: A nationwide approach.
   Am Heart J. 2026;291:111-120.
   

   >> Share

   
   December 2025
6. MILLS KT, Ferguson T, Lopez-Lopez JP, Duncan J, et al
   Caribbean and South American Team-based Strategy to Control Hypertension (CATCH): Rationale and study design of a cluster randomized trial.
   Am Heart J. 2025 Dec 17:107329. doi: 10.1016/j.ahj.2025.107329.
   

   >> Share

   
   October 2025
7. DORSCH MP, Dempsey W, Krambrink A, Ganai S, et al
   A Just-In-Time Adaptive Mobile Application Intervention to Reduce Sodium Intake and Blood Pressure in Patients with Hypertension: Rationale and Design of the LowSalt4Life 2 Trial.
   Am Heart J. 2025 Oct 27:107294. doi: 10.1016/j.ahj.2025.107294.
   

   >> Share

   
   July 2025
8. MAKUVIRE TT, Latif Z, Atwater S, Shah MK, et al
   Health Care Access and Risk Factor Control in US adults with Cardiovascular Disease from 2015 to 2023.
   Am Heart J. 2025 Jul 2:S0002-8703(25)00208-X. doi: 10.1016/j.ahj.2025.
   

   >> Share

   
   May 2025
9. TANG Y, Jiang C, Guo J, Li Y, et al
   Study protocol for the healthy family program on population blood pressure: A multicenter, parallel group, cluster randomized, controlled trial in rural China.
   Am Heart J. 2025;283:70-80.
   

   >> Share

   
   April 2025
10. LIYANAGE-DON N, Phillips E, Schwartz JE, Chang MJ, et al
    Implementing Remote Patient Monitoring to Improve Hypertension Control in a Primary Care Network: Rationale and Design of the Monitor-BP Cluster Randomized Trial.
    Am Heart J. 2025 Apr 8:S0002-8703(25)00122-X. doi: 10.1016/j.ahj.2025.
    

    >> Share

    
    
11. ANAND SC, Narowska G, Gangireddy C, Enevoldsen J, et al
    Novel automated electronic medical record-based VEST (virtual echocardiography screening tool) algorithm for pulmonary arterial hypertension.
    Am Heart J. 2025 Apr 5:S0002-8703(25)00102-4. doi: 10.1016/j.ahj.2025.
    

    >> Share

    
    February 2025
12. TIAN Y, Wang X, Hu Z, Yu X, et al
    Design, rationale, and characterization of the Mobile health based OccuPational cardiovascular risk intErventioN study (mHealth-OPEN Study).
    Am Heart J. 2025 Feb 13:S0002-8703(25)00035-3. doi: 10.1016/j.ahj.2025.
    

    >> Share

    
    December 2024
13. SANTORO F, Stiermaier T, Nunez Gil IJ, El-Battrawy I, et al
    Renin angiotensin system inhibitors and outcome in patients with takotsubo syndrome: A propensity score analysis of the GEIST registry.
    Am Heart J. 2024;278:127-138.
    

    >> Share

    
    November 2024
14. SALAM A, Sani MU, Ogah OS, Huffman MD, et al
    deliVERy of optimal blood pressure coNtrol in afrICA (VERONICA)-Nigeria study: Rationale and design of a randomized clinical trial.
    Am Heart J. 2024;277:66-75.
    

    >> Share

    
    September 2024
15. VOLPP KG, Mahraj K, Norton LA, Asch DA, et al
    Design and Rationale of Penn Medicine Healthy Heart, a Randomized Trial of Effectiveness of a Centrally Organized Approach to Blood Pressure and Cholesterol Improvement Among Patients at Elevated Risk of Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2024 Sep 26:S0002-8703(24)00262-X. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    
16. KERCHEVAL JB, Narcisse DI, Nguyen M, Rao SV, et al
    Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study.
    Am Heart J. 2024;275:183-190.
    

    >> Share

    
    August 2024
17. KIM CW, Haji M, Lopes VV, Halladay C, et al
    Variations in antihypertensive medication treatment and blood pressure control among Veterans with HIV and existing hypertension.
    Am Heart J. 2024 Aug 29:S0002-8703(24)00204-7. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    
18. SANNA GD, Erre GL, Cameli M, Guerra F, et al
    Association of sex with in-hospital management and outcomes of patients with heart failure: data from the REAL-HF registry: The impact of sex in patients hospitalized for heart failure.
    Am Heart J. 2024 Aug 27:S0002-8703(24)00221-7. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    
19. JIANG C, Wang Z, Du X, Wang Y, et al
    Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: rationale and design of the CRAFT trial.
    Am Heart J. 2024 Aug 23:S0002-8703(24)00203-5. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    
20. CHEN MT, Vollmer BL, Blyler CA, Cameron NA, et al
    Antihypertensive Medication Prescription Dispensation Among Pregnant Women in the United States: A Cohort Study.
    Am Heart J. 2024 Aug 21:S0002-8703(24)00205-9. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    July 2024
21. POLSINELLI VB, Koczo A, Johnson AE, Elkayam U, et al
    Race, Hypertensive Disorders of Pregnancy and Outcomes in Peripartum Cardiomyopathy.
    Am Heart J. 2024 Jul 10:S0002-8703(24)00168-6. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    June 2024
22. METLOCK FE, Kwapong YA, Evans C, Ouyang P, et al
    Design and Rationale of the Social Determinants of the Risk of Hypertension in Women of Reproductive Age (SAFE HEART) Study: An American Heart Association Research Goes Red Initiative.
    Am Heart J. 2024 Jun 9:S0002-8703(24)00138-8. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    May 2024
23. COMMODORE-MENSAH Y, Chen Y, Ogungbe O, Liu X, et al
    Design and Rationale of the Cardiometabolic Health Program Linked with Community Health Workers and Mobile Health Telemonitoring to Reduce Health DisparitieS (LINKED-HEARTS) Program.
    Am Heart J. 2024 May 15:S0002-8703(24)00123-6. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    April 2024
24. DAUBERT MA, Stebbins A, Peragallo-Urrutia R, Chiswell K, et al
    Early Postpartum Blood Pressure Screening is Associated with Increased Detection of Cardiovascular Risk Factors in Women with Hypertensive Disorders of Pregnancy.
    Am Heart J. 2024 Apr 4:S0002-8703(24)00076-0. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    
25. ZHANG H, Huo X, Ren L, Lu J, et al
    Design and rationale of the Comprehensive intelligent Hypertension managEment SyStem (CHESS) evaluation study: a cluster randomized controlled trial for hypertension management in primary care.
    Am Heart J. 2024 Apr 2:S0002-8703(24)00079-6. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    March 2024
26. MILLER HE, Tierney S, Stefanick ML, Mayo JA, et al
    Vascular health years after a hypertensive disorder of pregnancy: The EPOCH Study.
    Am Heart J. 2024 Mar 12:S0002-8703(24)00055-3. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    
27. HAMO CE, Schlamp F, Drenkova K, Jindal M, et al
    Burden of cardiometabolic risk factors and vascular health.
    Am Heart J. 2024;269:201-204.
    

    >> Share

    
    February 2024
28. MEHDIPOOR G, Redfors B, Chen S, Gkargkoulas F, et al
    Hypertension, Microvascular Obstruction and Infarct Size in Patients with STEMI Undergoing PCI: Pooled Analysis from 7 Cardiac Magnetic Resonance Imaging Studies.
    Am Heart J. 2024 Feb 29:S0002-8703(24)00050-4. doi: 10.1016/j.ahj.2024.
    

    >> Share

    
    December 2023
29. CHITTURI KR, Haberman D, Wermers JP, Waksman R, et al
    Overview of the 2023 FDA Circulatory System Devices Advisory Panel Meeting on the Symplicity Spyral Renal Denervation System.
    Am Heart J. 2023 Dec 19:S0002-8703(23)00350-2. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    November 2023
30. KIM M, Choi JH, Kim HK, Kim HL, et al
    Effects of Intensive Blood Pressure Control on Left Ventricular Hypertrophy in Aortic Valve Disease.
    Am Heart J. 2023 Nov 23:S0002-8703(23)00321-6. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
31. HAFF N, Sreedhara SK, Wood W, Yom-Tov E, et al
    Testing interventions to reduce clinical inertia in the treatment of hypertension: rationale and design of a pragmatic randomized controlled trial.
    Am Heart J. 2023 Nov 13:S0002-8703(23)00313-7. doi: 10.1016/j.ahj.2023.
    

    >> Share

    
    
32. GNANENTHIRAN SR, Tan I, Atkins ER, Avolio A, et al
    Transforming blood pressure control in primary care through a novel remote decision support strategy based on wearable blood pressure monitoring: The NEXTGEN-BP randomized trial protocol.
    Am Heart J. 2023;265:50-58.
    

    >> Share

    
    
33. BERMAN AN, Ginder C, Wang XS, Borden L, et al
    A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH).
    Am Heart J. 2023;265:40-49.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share